WallStreetZenWallStreetZen

NASDAQ: CARL
Carlsmed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CARL

Based on 4 analysts offering 12 month price targets for Carlsmed Inc

Min Forecast
$18.00+20.08%
Avg Forecast
$20.25+35.09%
Max Forecast
$24.00+60.11%

Should I buy or sell CARL stock?

Based on 4 analysts offering ratings for Carlsmed Inc.

Strong Buy
Strong Buy
4 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CARL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CARL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CARL stock forecasts and price targets.

CARL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-07
lockedlocked$00.00+00.00%2025-11-07Find Out Why
lockedlocked$00.00+00.00%2025-08-18
lockedlocked$00.00+00.00%2025-08-18

1 of 1

Forecast return on equity

Is CARL forecast to generate an efficient return?

Company
-27.21%
Industry
20.66%
Market
230.71%
CARL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CARL forecast to generate an efficient return on assets?

Company
-21.52%
Industry
17.04%
CARL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CARL earnings per share forecast

What is CARL's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$2.44
Avg 2 year Forecast
-$1.69
Avg 3 year Forecast
-$1.50

CARL revenue forecast

What is CARL's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$50.6M
Avg 2 year Forecast
$71.2M
Avg 3 year Forecast
$101.1M

CARL vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
CARL$14.99$20.25+35.09%Strong Buy
NRC$16.79N/AN/A
DH$2.66$5.00+87.97%Buy
OWLT$13.00N/AN/A
EVH$4.00$10.85+171.25%Strong Buy
View Top Health Information Service Stocks

Carlsmed Stock Forecast FAQ

Is Carlsmed Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CARL) stock is to Strong Buy CARL stock.

Out of 4 analysts, 4 (100%) are recommending CARL as a Strong Buy, 0 (0%) are recommending CARL as a Buy, 0 (0%) are recommending CARL as a Hold, 0 (0%) are recommending CARL as a Sell, and 0 (0%) are recommending CARL as a Strong Sell.

If you're new to stock investing, here's how to buy Carlsmed stock.

What is CARL's earnings growth forecast for 2025-2027?

(NASDAQ: CARL) Carlsmed's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 32.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.12%.

Carlsmed's earnings in 2025 is N/A.On average, 7 Wall Street analysts forecast CARL's earnings for 2025 to be -$64,828,191, with the lowest CARL earnings forecast at -$91,734,895, and the highest CARL earnings forecast at -$43,000,732. On average, 7 Wall Street analysts forecast CARL's earnings for 2026 to be -$45,027,112, with the lowest CARL earnings forecast at -$52,903,931, and the highest CARL earnings forecast at -$37,136,996.

In 2027, CARL is forecast to generate -$40,009,030 in earnings, with the lowest earnings forecast at -$42,740,122 and the highest earnings forecast at -$37,695,447.

What is CARL's revenue growth forecast for 2025-2027?

(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.

Carlsmed's revenue in 2025 is N/A.On average, 7 Wall Street analysts forecast CARL's revenue for 2025 to be $1,346,691,454, with the lowest CARL revenue forecast at $1,290,021,967, and the highest CARL revenue forecast at $1,392,564,220. On average, 7 Wall Street analysts forecast CARL's revenue for 2026 to be $1,893,973,501, with the lowest CARL revenue forecast at $1,739,309,148, and the highest CARL revenue forecast at $2,037,282,682.

In 2027, CARL is forecast to generate $2,688,011,141 in revenue, with the lowest revenue forecast at $2,404,397,777 and the highest revenue forecast at $2,836,931,425.

What is CARL's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CARL) forecast ROA is -21.52%, which is lower than the forecast US Health Information Services industry average of 17.04%.

What is CARL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CARL price target, the average CARL price target is $20.25, with the highest CARL stock price forecast at $24.00 and the lowest CARL stock price forecast at $18.00.

On average, Wall Street analysts predict that Carlsmed's share price could reach $20.25 by Nov 7, 2026. The average Carlsmed stock price prediction forecasts a potential upside of 35.09% from the current CARL share price of $14.99.

What is CARL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CARL) Carlsmed's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that CARL's EPS will be -$2.44 for 2025, with the lowest EPS forecast at -$3.45, and the highest EPS forecast at -$1.62. On average, analysts forecast that CARL's EPS will be -$1.69 for 2026, with the lowest EPS forecast at -$1.99, and the highest EPS forecast at -$1.40. In 2027, CARL's EPS is forecast to hit -$1.50 (min: -$1.61, max: -$1.42).

What is CARL's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CARL) forecast ROE is -27.21%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.